IGFBP1 and obesity disorder: Interestingly, trending increases were detected for IGFBP-1 in non-obese tumor-free donors versus those with obesity (P = 0.05) and in non-obese ccRCC subjects versus non-obese tumor-free donors (P = 0.08).